| pubmed-article:16790517 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16790517 | lifeskim:mentions | umls-concept:C0679729 | lld:lifeskim |
| pubmed-article:16790517 | lifeskim:mentions | umls-concept:C0278996 | lld:lifeskim |
| pubmed-article:16790517 | lifeskim:mentions | umls-concept:C1518578 | lld:lifeskim |
| pubmed-article:16790517 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:16790517 | lifeskim:mentions | umls-concept:C0004927 | lld:lifeskim |
| pubmed-article:16790517 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:16790517 | lifeskim:mentions | umls-concept:C1522690 | lld:lifeskim |
| pubmed-article:16790517 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:16790517 | lifeskim:mentions | umls-concept:C0010171 | lld:lifeskim |
| pubmed-article:16790517 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:16790517 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:16790517 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:16790517 | pubmed:dateCreated | 2006-9-28 | lld:pubmed |
| pubmed-article:16790517 | pubmed:abstractText | The prognosis of patients with recurrent and/or metastatic head and neck cancer (HNC) is poor. Median survival of these patients following chemotherapy is in the range of 6 to 9 months. In the present randomized phase III trial we compared two new combinations containing new drugs with proven activity in phase II studies with patients with HNC. | lld:pubmed |
| pubmed-article:16790517 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16790517 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16790517 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16790517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16790517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16790517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16790517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16790517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16790517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16790517 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16790517 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16790517 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:StathopoulosG... | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:DaniilidisJJ | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:PavlidisNN | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:Christodoulou... | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:Economopoulos... | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:NikolaouAA | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:FountzilasGG | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:BafaloukosDD | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:Kalogera-Foun... | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:BamiasAA | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:SyrigosKK | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:AravantinosGG | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:PapakostasPP | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:DafniUU | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:ManiadakisNN | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:MakatsorisTT | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:AngouridakisN... | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:KarinaMM | lld:pubmed |
| pubmed-article:16790517 | pubmed:author | pubmed-author:KalofonosHpH | lld:pubmed |
| pubmed-article:16790517 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16790517 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:16790517 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16790517 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16790517 | pubmed:pagination | 1560-7 | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:meshHeading | pubmed-meshheading:16790517... | lld:pubmed |
| pubmed-article:16790517 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16790517 | pubmed:articleTitle | Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group. | lld:pubmed |
| pubmed-article:16790517 | pubmed:affiliation | Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Macedonia, Greece. fountzil@med.auth.gr | lld:pubmed |
| pubmed-article:16790517 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16790517 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16790517 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:16790517 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
